Introducing pharmacogenetic testing with clinical decision support into primary care: a feasibility study

M Dawes, MN Aloise, JS Ang, P Cullis… - … Open Access Journal, 2016 - cmajopen.ca
Background: Inappropriate prescribing increases patient illness and death owing to adverse
drug events. The inclusion of genetic information into primary care medication practices is …

[HTML][HTML] Consideration of patient preferences and challenges in storage and access of pharmacogenetic test results

SB Haga, K Kawamoto, R Agans, GS Ginsburg - Genetics in Medicine, 2011 - nature.com
Purpose: Pharmacogenetic testing is one of the primary drivers of personalized medicine.
The use of pharmacogenetic testing may provide a lifetime of benefits through tailoring drug …

Implementation of a multidisciplinary pharmacogenomics clinic in a community health system

HM Dunnenberger, M Biszewski, GC Bell… - American Journal of …, 2016 - academic.oup.com
Purpose The development and implementation of a multidisciplinary pharmacogenomics
clinic within the framework of an established community-based medical genetics program …

Pharmacogenetics and practice: tailoring prescribing for safety and effectiveness

CR Fulton, M Swart, T De Luca, SN Liu… - The Journal for Nurse …, 2018 - Elsevier
Precision medicine involves using information on the effect of DNA sequence variations,
together with environmental and lifestyle exposures, to improve disease prevention and …

[HTML][HTML] What do we need to transfer pharmacogenetics findings into the clinic?

EMA Slob, SJH Vijverberg, MW Pijnenburg… - …, 2018 - Future Medicine
Recently, a portable USB compatible handheld DNA sequencer became commercially
available to genotype individuals without need of a laboratory [1]. However, does the rise of …

Pharmacogenomic testing to support prescribing in primary care: a structured review of implementation models

J Hayward, J McDermott, N Qureshi… - …, 2021 - Future Medicine
The application of pharmacogenomics could meaningfully contribute toward medicines
optimization within primary care. This review identified 13 studies describing eight …

[HTML][HTML] Primary care clinicians attitudes and knowledge of pharmacogenetics in a large, multi-state, healthcare system

M Olander, S Waring, DD Stenehjem… - INNOVATIONS in …, 2018 - ncbi.nlm.nih.gov
Background Considerable progress has been made in the way of pharmacogenetic
research and the development of clinical recommendations; however, its implementation …

The innovative Canadian pharmacogenomic screening initiative in community pharmacy (ICANPIC) study

J Papastergiou, P Tolios, W Li, J Li - Journal of the American Pharmacists …, 2017 - Elsevier
Objectives The safety and efficacy of medications can vary significantly between patients as
a result of genetic variability. As genomic screening technologies become more widely …

Clinical and regulatory considerations in pharmacogenetic testing

RN Schuck, E Marek, H Rogers… - American Journal of …, 2016 - academic.oup.com
Purpose Both regulatory science and clinical practice rely on best available scientific data to
guide decision-making. However, changes in clinical practice may be driven by numerous …

[HTML][HTML] Exploring perceptions, knowledge, and attitudes regarding pharmacogenetic testing in the medically underserved

BE Gawronski, EJ Cicali, CW McDonough… - Frontiers in …, 2023 - frontiersin.org
Introduction: Pharmacogenetic testing may hold promise in addressing health disparities, as
medically underserved patients appear to be prescribed medications with pharmacogenetic …